Z-1295-2018 Class II Terminated
FDA device recall Z-1295-2018 was initiated by Magellan Diagnostics, Inc. on Jan 9, 2018 and is designated Class II. Reason for recall: The incorrect placement of AA batteries into certain LeadCare II Blood Lead Analyzer may cause the batteries to overheat, and the chance that a user could burn their fingers if the batteries are… The recall status is terminated (terminated Dec 11, 2020). Affected quantity: 6,143.
Recall details
- Product Type
- Devices
- Report Date
- Apr 11, 2018
- Initiation Date
- Jan 9, 2018
- Termination Date
- Dec 11, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,143
Product description
LeadCare II Blood Lead Analyzer Part Numbers: 70-6760, 70-6529-R, 70-6760-P, 70-6760-R. Intended for in vitro (external) use only.
Reason for recall
The incorrect placement of AA batteries into certain LeadCare II Blood Lead Analyzer may cause the batteries to overheat, and the chance that a user could burn their fingers if the batteries are removed while hot.
Distribution pattern
Worldwide Distribution
Code information
Part Numbers: 70-6760, 70-6529-R, 70-6760-P, and 70-6760-R. All LeadCare II and LeadCare Plus Blood Lead Analyzers with battery boards versions B and O.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1295-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026